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Cerebral salt-wasting (CSW), or renal salt-wasting (RSW), has
evolved from a misrepresentation of the syndrome of
inappropriate secretion of antidiuretic hormone (SIADH) to
acceptance as a distinct entity. Challenges still confront us as
we attempt to differentiate RSW from SIADH, ascertain the
prevalence of RSW, and address reports of RSW occurring
without cerebral disease. RSW is redefined as ‘extracellular
volume depletion due to a renal sodium transport
abnormality with or without high urinary sodium
concentration, presence of hyponatremia or cerebral disease
with normal adrenal and thyroid function.’ Our inability to
differentiate RSW from SIADH lies in the clinical and
laboratory similarities between the two syndromes and the
difficulty of accurate assessment of extracellular volume.
Radioisotopic determinations of extracellular volume in
neurosurgical patients reveal renal that RSW is more
common than SIADH. We review the persistence of
hypouricemia and increased fractional excretion of urate in
RSW as compared to correction of both in SIADH, the
appropriateness of ADH secretion in RSW, and the
importance of differentiating renal RSW from SIADH because
of disparate treatment goals: fluid repletion in RSW and
fluid restriction in SIADH. Patients with RSW are being
incorrectly treated by fluid restriction, with clinical
consequences. We conclude that RSW is common and
occurs without cerebral disease, and propose changing
CSW to RSW.
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OBJECTIVES
Cerebral salt wasting (CSW) or, more appropriately, renal salt
wasting (RSW), is a syndrome with a controversial history
that evolved from a misrepresentation of inappropriate
secretion of antidiuretic hormone (SIADH) to acceptance
as a distinct entity. Challenges confront us as we attempt to
find clues to differentiate RSW from SIADH, ascertain the
prevalence of RSW, and address reports of RSW occurring
without cerebral disease.1,2 The objectives of this mini review
are to redefine RSW, explain how this controversy evolved,
emphasize the appropriateness of antidiuretic hormone
(ADH) secretion in RSW, differentiate RSW from SIADH
by the persistence of hypouricemia and increased fractional
excretion (FE) of the urate after correction of hyponatremia
in RSW, stress the clinical importance of differentiating RSW
from SIADH because of divergent therapeutic goals of fluid
repletion in RSWor fluid restriction in SIADH, and advocate
changing CSW to RSW.
DEFINITION OF RSW: EVOLUTION OF CONTROVERSY
RSW is defined as, ‘extracellular volume (ECV) depletion due
to a renal sodium transport abnormality with or without
high urinary sodium concentration (UNa), presence of
hyponatremia, or cerebral disease with normal adrenal and
thyroid function’. Although this definition delineates the
salient features of RSW, its existence has been an enduring
controversy since the seminal description of SIADH.3 The
previous report of CSW was based on an inappropriately
high urine chloride of 61.6mmol/l in a clinically ‘dehydrated’
patient with cerebral disease.4 As volume-depleted patients
with normal kidneys avidly conserve salt, the urine
chloride of 61.6mmol/l was best explained by RSW.5 When
Schwartz et al.3 encountered patients who mimicked normal
individuals receiving exogenous ADH, it became apparent
that an euvolemic hyponatremic patient can present with
high UNa without implicating RSW. As the diagnosis of
‘dehydration’ was made by inaccurate clinical criteria, CSW
was regarded as a misnomer of SIADH and considered
nonexistent or rare.
The overlapping clinical and laboratory characteristics
have largely perpetuated the diagnostic and therapeutic
dilemma of restricting water in SIADH, or administering salt
and water in RSW. Both present with normal adrenal and
thyroid function, hyponatremia, hypouricemia, concentrated
urine with UNa usually 420mmol/l, and FEurate 410%.
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Euvolemia in SIADH and ECV depletion in RSWare the only
variables that differentiate SIADH from RSW on first
encounter, but clinical assessment of ECV is inaccurate.6
Treatment for RSW, however, can be initiated if FEphosphate
is 420% on first encounter.2 Moreover, exceptions and
misconceptions have fueled this controversy, although it can
be concluded that RSW is a clinical entity that is more
common than is perceived and must now be considered in
those without cerebral disease.1,2
VOLUME STUDIES
The difficulty to assess ECV accurately and adherence to the
notion that RSW is a misnomer of SIADH are major reasons
for this longstanding diagnostic dilemma. Accurate determi-
nations of ECV should, therefore, resolve this dilemma.
Determination of ECV by radioisotope dilution is the gold
standard, which correlates poorly with concomitant central
venous pressure (CVP) measurements, suggesting that CVP
is an unreliable determinant of ECV.7 Nelson et al. measured
blood volume by 51Cr-tagged red cells and 131I-tagged
albumin in 12 hyponatremic neurosurgical patients as
compared with that in 6 control patients. Of the 10 patients
with decreased blood volume, 8 had subarachnoid hemor-
rhage (SAH) and 2 had increased blood volume, suggesting
that 10 had RSW and 2 SIADH.8 The UNa ranged from 41 to
203mmol/l.8 Wijdicks et al. measured plasma volume by
131I-tagged albumin in 21 patients on the first day of
admission within 48 h after SAH and on the sixth day after
SAH. They compared differences between both the measure-
ments to determine ECV while receiving at least 1500ml of
fluid daily and comparable sodium intake. Of the nine
hyponatremic patients, plasma volume decreased by 10–20%
in six, o10% in two, and increased by 4% in one.9
Interestingly, in 12 normonatremic patients, plasma volume
decreased by410% in 5,o10% in 3, and increased by45%
in 4. Moreover, all 8 hyponatremic patients and 10 of 12
normonatremic patients with decreased plasma volume were
in negative sodium balance.9 This study concurs with
Nelson’s study and shows that RSW can occur without
hyponatremia.9 In a study of hyponatremic patients with
diverse neurosurgical diseases meeting criteria for SIADH,
Sivakumar et al. found hypovolemia in 17 of 18 hypona-
tremic patients using 51Cr-tagged red cells. All 18 patients
had decreased CVPs.10 UNa ranged from 43 to 210mmol/l
and all 18 patients corrected their hyponatremia within 72 h
after initiating saline therapy, which was consistent with RSW
and not SIADH.1,2,10 In a retrospective study of 319 patients
with SAH, Sherlock et al. found 179 hyponatremic patients
meeting the criteria for SIADH and CSW. They found that
69.2% had SIADH, 6.5% CSW, and 4.8% had combined
SIADH and CSW. ECV was determined by CVP measure-
ments, presence of hypotension, and undefined parameters.11
This report suffers by its retrospective design, paucity of data
to support their diagnoses, and reliance on CVP measure-
ments that are poor determinants of ECV.7 Moreover, the
combination of SIADH and CSW in 4.8% of patients lacked
supportive data to justify such a mutually exclusive
diagnostic combination. In total, 10 patients with AIDS with
saline-responsive postural hypotension were selectively stu-
died. All the patients had CVP of 0 cm water, increased renin
and aldosterone, hyponatremia, hypouricemia, elevated
FEurate, and UNa 440mmol/l, which collectively support
the diagnosis of RSW.6 Overall, these volume studies support
the notion that RSW not only exists but is more common
than SIADH in neurosurgical patients.
PATHOPHYSIOLOGY OF RSW AND SIADH
In RSW, the initiating defect in renal sodium transport leads
to ECV depletion and multiple compensatory changes. At the
onset, sodium excretion exceeds sodium input to decrease
ECV, but as compensatory hemodynamic and neurohumoral
factors come into play, the patient enters an equilibrated state
where sodium input matches output. As in our well-
documented case of RSW, UNa can thus be as low as
6mmol/l when sodium intake is low.1 The final ECV depends
on the extent of the renal sodium transport defect and
sodium input. The reduced effective arteriolar volume
activates baroreceptors that increase ADH secretion and
increase water conservation. As insensible fluid losses are
hypotonic, the tendency to develop hypernatremia must be
overcome by adequate free water intake for hyponatremia to
develop. In those with defective thirst as seen in the aged or
demented, such as Alzheimer’s disease (AD), RSW can occur
without hyponatremia or even hypernatremia.12 As will be
discussed later, the presence of increased FEurate and lower
serum urate in the absence of hyponatremia and demonstra-
tion of natriuretic activity in AD plasma suggest that RSW is
common in those with moderate-to-severe AD.12 In RSW the
volume stimulus for ADH secretion overrides the usual
inhibition by the coexisting plasma hypoosmolality. The ECV
depletion stimulates aldosterone production, but the prox-
imal sodium transport defect in RSW will maintain
salt supply to the distal nephron when salt intake is adequate
to yield normal cyclo-oxygenase 2 activity and renin
production.13
The primary defect in SIADH is the euvolemic, inap-
propriate increase in plasma ADH levels. With adequate free
water intake, the increase in water reabsorption induces
hyponatremia, plasma hypoosmolality, and a small degree of
volume expansion, which along with increased atrial natri-
uretic peptide levels, decrease plasma renin and aldosterone.6
There is an initial salt wasting and water retention,
often leading to an equilibrated state of vasopressin escape
where sodium and water input matches output, possibly
due to a reduction in V2 receptor and urea transporter 2.2,6
The hypouricemia and increased FEurate occurring only
during the period of hyponatremia have not been adequately
explained but cannot be ascribed to V1 activity of ADH
because ADH levels are increased even after correction
of hyponatremia when FEurate returns to normal
(Figure 1b).6,14 Moreover, the induction of SIADH by
desmopressin acetate, which lacks V1 activity, was associated
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with an increase in FEurate.15 ECVexpansion as with saline is
known to have a meager effect on FEurate but not to the
extent seen in SIADH.14
VALUE OF FEurate OVER HYPOURICEMIA
Beck16 proposed that the coexistence of hyponatremia and
hypouricemia, defined as serum urate p4mg per 100ml,
differentiated SIADH from most other causes of hypona-
tremia. The hypouricemia was largely due to increased
FEurate. Interestingly, the hypouricemia and increased
FEurate corrected after correction of the hyponatremia.16
This relationship between sodium and urate has been
observed by others in SIADH (Figure 1a).14,16,17 We used
this relationship between serum sodium, and serum urate
and FEurate to differentiate SIADH from a group of patients
whose hypouricemia and increased FEurate persisted after
correction of their hyponatremia (Figure 1b).6,14 One
hyponatremic patient with bronchogenic carcinoma, normal
CT scan of brain, and normal neurological examination,
became profoundly volume-depleted during water restriction
for an erroneous diagnosis of SIADH with postural
hypotension, postural tachycardia, dry mucous membranes,
flat neck veins, tenting of skin, and staggered gait, drooping
of eyes, somnolence, and slurred speech on standing.18 After
his serum sodium increased to 138mmol/l, his hypouricemia
and increased FEurate persisted.18 This and two other
patients without cerebral disease prompted our concern that
cerebral disease was not an invariable association in RSW.18
Increased FEurate with or without hyponatremia or
hypouricemia was also noted in AIDS, as noted above, and
all but two hyponatremic patients with diverse neurosurgical
diseases and AD.6,14 The persistence of hypouricemia and
increased FEurate after correction of hyponatremia or in
association with a normal serum sodium was inconsistent
with SIADH and in our view represented a group with RSW
(Figure 1b).1,2,6,14 The persistent hypouricemia and increased
FEurate that we reported in two patients with indisputable
evidence of RSW supported our earlier proposal that this
combination was a feature of RSW and that RSW can occur
in patients without cerebral disease.1,2 One had a hip fracture
and the other pneumonia. Both were treated for an erroneous
diagnosis of SIADH with fluid restriction, which induced
anorexia and low sodium intake to account for the UNa of
6mmol/l in the patient with a hip fracture.1 She was initially
thought to be a hypovolemic patient with normal kidneys,
but the serum urate of 3.4mg per 100ml and FEurate of
29.6% were more consistent with either SIADH or RSW.1,5
The 7.1% reduction in blood volume, increased plasma renin
and aldosterone levels, and persistence of hypouricemia and
increased FEurate after correction of hyponatremia were
collectively diagnostic of RSW.1 This case illustrates how a
low sodium intake can result in low UNa in RSW, as sodium
output reflects input when in an equilibrated state. In both
cases without cerebral disease, saline removed the volume
stimulus for ADH secretion and permitted the coexisting
plasma hypoosmolality to inhibit ADH secretion, generate
free water excretion, and correct the hyponatremia within
48 h (Figure 2).1,2 Plasma ADH was undetectable when the
urine was dilute in the patient with the hip fracture, a finding
that illustrates the ‘appropriateness’ of ADH secretion in
RSW.1 The two cases of RSW strengthened our previous
proposal that an increased FEurate in the absence of hypo-
natremia is a marker for RSW and support the applicability
of our rat infusion studies to RSW (Figure 1b).6,14 Finally, the
baseline FEphosphate of 23% (normalo20%) in one patient
is consistent with RSW, as FEphosphate was not present in
the two patients with SIADH or reported in SIADH, and is a
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Figure 1 |Relationship between serum sodium, serum urate,
and FEurate in SIADH and RSW. Relationship between serum
sodium, serum urate, and FEurate in (a) inappropriate secretion of
antidiuretic hormone (SIADH) and (b) renal salt wasting (RSW).
Shaded areas represent normal values for each laboratory test.
Hypouricemia and increased FEurate coexist with hyponatremia in
both SIADH and RSW, but return to normal values with correction
of hyponatremia in SIADH. In contrast, hypouricemia and
increased FEurate persist after correction of hyponatremia in RSW.
Serum sodium (orange), serum urate (green) and FEurate (red).
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Figure 2 |Response of urine Osm and serum sodium
concentration to saline infusion at 125ml/h in hyponatremic
patient with hip fracture without cerebral disease. Plasma
antidiuretic hormone (ADH) was undetectable when urine Osm
was 178mOsm/kg water. Patient had 7.1% reduction in blood
volume, increased plasma renin and aldosterone, and persistent
hypouricemia and increased FEurate after correction of
hyponatremia. Note prompt correction of hyponatremia after
inhibition of ADH secretion and generation of dilute urine to
increase free-water excretion.1
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clue to infuse saline when present at baseline.2 The increase in
FEurate, occasional increase in FEphosphate, and increased
FElithium in our rat infusion studies all favor the proximal
tubule as the major site of defective solute transport in
RSW.1,2,14
ABSENCE OF PRERENAL AZOTEMIA IN RSW
The BUN to creatinine ratio normally expected in prerenal
azotemia is often absent and does not differentiate RSW from
SIADH. In our well-documented cases of RSW and SIADH,
we were unable to show an increase in BUN to creatinine
ratio in RSW as compared with SIADH, being 14 and 20 to 1
in RSW and 15.7 and 23.3 to 1 in SIADH.8,9 This is an
important issue to clarify with actual data because it focuses
on a fundamental physiological abnormality in RSW that
differs from those with ECV depletion and normal kidney
function. The intact proximal tubule responds to ECV
depletion by increasing reabsorption of urea and other
solutes over a nonreabsorbable creatinine to increase the
BUN to creatinine ratio in prerenal azotemia. The increases
in FEurate, occasional FEphosphate and in our rat studies,
FElithium, support our assertion that the proximal tubule is
the major site of defective solute transport in RSW. The
reduction in sodium and water reabsorption in the proximal
tubule reduces the transtubular urea gradient to decrease
passive urea reabsorption to prevent the disproportionate
increase in BUN over creatinine. The renal response to ECV
depletion in RSW, therefore, cannot be equated to those with
ECV depletion and normal kidney function.
DIFFERENTIATING RSW FROM SIADH
Determination of ECV by radioisotopic techniques in
neurosurgical patients suggests that RSW, especially those
with SAH, is more common than SIADH in this population,
but its overall prevalence is yet to be determined. This can be
ascribed to several factors: consideration of RSW enters the
differential only in hyponatremic patients or those with
cerebral disease; patients who are normonatremic and without
cerebral disease are being overlooked; and hyponatremia
occurs less frequently in neurosurgical units because isotonic
saline is the fluid of choice.19 Saline is the treatment of choice
because fluid restriction in neurosurgical units, especially those
with SAH, increases morbidity and mortality.19 We and others
have encountered instances where fluid restriction for an
erroneous diagnosis of SIADH led to clinical deterioration of
the patient with RSW.1,15 The combination of the difficulty to
differentiate RSW from SIADH, and occurrence of RSW with
and without cerebral disease or hyponatremia contribute to
the diagnostic and therapeutic dilemma.
Although differentiating RSW from SIADH on first
encounter can be made only by differences in ECV and by
an occasional increase in FEphosphate 420%, there are
differences that can contribute to making the proper diagnosis
and treatment plan. An increase in FEphosphate has been
reported in RSW but not in SIADH.2 FEphosphate should be
determined before administering saline. We have shown by
clearance and micropuncture studies that saline or mannitol
can promptly increase FEphosphate by acutely decreasing
serum calcium and magnesium to stimulate parathyroid
hormone secretion.20 We are uncertain what the FEphosphate
should be during variable degrees of volume depletion and
normal kidney function. The increase in baseline plasma renin
and aldosterone levels in RSW can differentiate RSW from the
usually depressed levels found in SIADH,1,2 Plasma renin,
however, can be normal in RSW if the patient is ingesting
sufficient amounts of salt (Table 1).2 The defect in proximal
salt transport maintains an adequate distal salt load to blunt
cyclo-oxygenase 2 and renin production.19
NATRIURETIC FACTOR IN RSW
The persistence of hypouricemia and increased FEurate in the
absence of hyponatremia in RSWaffords greater credibility to
our earlier rat clearance studies in which we infused the
plasma of largely nonhyponatremic neurosurgical and AD
patients with increased FEurates.6,12,14 When compared with
plasma from age- and gender-matched controls, there were
significant increases in both FElithium and FENa.6,12,14 As
lithium is reabsorbed on a one-to-one basis with sodium
predominantly in the proximal tubule, the increase in
FElithium from 24 to 36.6% and from 27.2 to 41.7% in
rats exposed to neurosurgical and AD plasma, respectively,
reflects the reduction in proximal tubule sodium transport
and large distal load of sodium.6,12,14 The relatively modest
increase in FENa from 0.29 to 0.59% and 0.33 to 0.63% in
rats exposed to neurosurgical and AD plasma, respectively,
suggests significant compensatory increase in distal sodium
reabsorption, although a mild inhibition of distal sodium
transport by the natriuretic factor might also be present.6,12,14
These results support our clinical impression that the
proximal tubule is the major site of abnormal solute
transport in RSW. As urate and phosphate, like lithium, are
exclusively or predominantly transported in the proximal
tubule, the increased FEurate and occasional FEphosphate in
our patients supports the findings in our rat studies, that the
proximal tubule is the major site of solute transport
abnormality in RSW. Future studies must test whether the
natriuretic factor in RSW affects one or more of the
transporters for sodium, urate, phosphate, and urea.
Table 1 | Differentiation of SIADH from RSW
RSW SIADH
ECV k N-m
UNa N-m N-m
Renin ±m ±k
Aldosterone m ±k
Serum urate k-k k-N
FEurate mm m-N
FEphosphate ±m N
ECV, extracellular volume; RSW, renal salt wasting; SIADH, secretion of antidiuretic
hormone; UNa, urinary sodium concentration.
Table comparing laboratory expectations for RSW and SIADH. UNa can be normal or
often 420mmol/l; serum urate and FEurate are increased during hyponatremia in
both RSW and SIADH but differ when serum is normal. Serum urate and FEurate
remain abnormal in RSW and normalize in SIADH when serum sodium is normal.
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Atrial/brain natriuretic peptides, including urodilatin,
have been implicated as possible causes of RSW, but their
contribution to RSW is not supported by their modest effect
on sodium and other solute transport. These peptides are
vasodilators that increase sodium excretion by increasing
glomerular filtration rates and a meager effect on distal
sodium transport.21 The administration of atrial natriuretic
peptide in normal humans had no effect on lithium excretion
rates. The plasma from our neurosurgical and AD patients
failed to decrease blood pressure or increase GFR, and the
low-normal atrial natriuretic peptide of 35 pg/ml in our hip
fracture patient makes it highly unlikely that atrial/brain
natriuretic peptides or urodilatin contribute to the salt
wasting in RSW.6,12,14
CHANGE CSW TO RSW
As discussed above, RSW is more common than SIADH in
neurosurgical patients and with the recent reports of RSW
occurring in patients without clinical cerebral disease, we
must expand our differential to include RSW in patients
without cerebral disease.1,2 Both cases of RSW without
cerebral disease were treated by water restriction for an
erroneous diagnosis of SIADH.1,2 Fluid restriction in RSW
can lead to variable clinical manifestations depending on the
severity of the sodium transport defect and ECV depletion.1,6
In our present state of understanding these two disorders, it
would be interesting to query how many patients with RSW
with or without cerebral disease are being fluid restricted for
an erroneous diagnosis of SIADH. The extent of their clinical
deterioration may depend on the severity of their underlying
sodium transport defect and reduced fluid intake, and not on
deterioration of their underlying disease. It is time to discard
the outmoded, misleading, and inappropriate term, CSW, in
favor of a more inclusive RSW. This change in designation,
however, will have limited utility unless we can identify those
who are likely to have RSW and improve our ability to
differentiate RSW from SIADH on first encounter. The
combination of diametrically opposing treatment goals and
awareness that RSW is a common disorder occurring without
hyponatremia or cerebral disease should hasten our pursuit
to resolve the diagnostic and therapeutic dilemma, and
improve clinical outcomes.
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